Keith Faucher

Keith Faucher

Company: Aura Biosciences

Job title: Sr. Director Device Development & Innovation


Understanding the Evolving Extractables & Leachables (E&L) Regulatory Expectations to Circumvent Drug Product Approval Delays 12:30 pm

Highlighting potential drug-device interactions early on in development to reduce risk and achieve the best possible outcome Exploring E&L testing and analysis to quantify and assess risks associated with leachable impurities Reviewing regulatory requirements within Extractable & Leachable testing for combination productsRead more

day: Day One

A Hanson Wade Group Company

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.